We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+4.27%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$203B
AUM Growth
+$19.6B
Cap. Flow
+$8.95B
Cap. Flow %
4.4%
Top 10 Hldgs %
24.49%
Holding
9,765
New
1,572
Increased
4,160
Reduced
2,819
Closed
1,012

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$702M
2
AMAT icon
Applied Materials
AMAT
+$507M
3
KDP icon
Keurig Dr Pepper
KDP
+$387M
4
KEY icon
KeyCorp
KEY
+$383M
5
V icon
Visa
V
+$349M

Sector Composition

Rank Sector Weight
1 Financials 6.16%
2 Technology 4.5%
3 Industrials 4.26%
4 Consumer Discretionary 4.07%
5 Healthcare 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NPTN
7826
CALL
DELISTED
NEOPHOTONICS CORP
NPTN
$174K ﹤0.01%
28,000
-96,800
-78% -$616K
CALA
7827
PUT
DELISTED
Calithera Biosciences, Inc
CALA
$174K ﹤0.01%
1,735
+650
+60% +$73.6K
SPN
7828
PUT
DELISTED
Superior Energy Services, Inc.
SPN
$174K ﹤0.01%
+1,790
New +$184K
ASRT
7829
PUT
DELISTED
Assertio
ASRT
$173K ﹤0.01%
433
+45
+12% +$18.3K
IMUX icon
7830
PUT
Immunic
IMUX
$190M
$173K ﹤0.01%
+63
New +$146K
LCTX icon
7831
Lineage Cell Therapeutics
LCTX
$269M
$173K ﹤0.01%
95,967
-105,587
-52% -$213K
RAD
7832
CALL
DELISTED
Rite Aid Corporation
RAD
$173K ﹤0.01%
4,990
-1,600
-24% -$54.3K
SRCI
7833
DELISTED
SRC Energy Inc
SRCI
$173K ﹤0.01%
15,683
-3,964,977
-100% -$44.2M
NSTG
7834
DELISTED
NanoString Technologies, Inc.
NSTG
$172K ﹤0.01%
12,584
-55,990
-82% -$640K
NEOS
7835
DELISTED
Neos Therapeutics, Inc
NEOS
$171K ﹤0.01%
+27,298
New +$204K
CIA icon
7836
Citizens
CIA
$239M
$170K ﹤0.01%
+21,816
New +$168K
INO icon
7837
PUT
Inovio Pharmaceuticals
INO
$55.7M
$170K ﹤0.01%
3,617
+1,309
+57% +$72.2K
RWT
7838
CALL
Redwood Trust
RWT
$574M
$170K ﹤0.01%
+10,300
New +$165K
AXAS
7839
DELISTED
Abraxas Petroleum Corp
AXAS
$170K ﹤0.01%
2,954
+97
+3% +$5.25K
AWF
7840
AllianceBernstein Global High Income Fund
AWF
$870M
$169K ﹤0.01%
14,605
-1,328
-8% -$15.5K
CAPL icon
7841
CALL
CrossAmerica Partners
CAPL
$847M
$169K ﹤0.01%
10,000
-1,100
-10% -$20.7K
CLPS icon
7842
CLPS Inc
CLPS
$25.6M
$169K ﹤0.01%
+13,083
New +$109K
HMY icon
7843
PUT
Harmony Gold Mining
HMY
$9.84B
$169K ﹤0.01%
108,300
+92,600
+590% +$173K
CMRX
7844
DELISTED
Chimerix, Inc.
CMRX
$169K ﹤0.01%
35,611
-67,575
-65% -$323K
ZMLP
7845
DELISTED
Direxion Zacks MLP High Income Index Shares
ZMLP
$169K ﹤0.01%
+1,430
New +$170K
AVDL
7846
PUT
DELISTED
Avadel Pharmaceuticals
AVDL
$168K ﹤0.01%
27,400
+2,000
+8% +$14K
GYRE icon
7847
Gyre Therapeutics
GYRE
$641M
$168K ﹤0.01%
+1,923
New +$337K
NGVC icon
7848
Vitamin Cottage Natural Grocers
NGVC
$739M
$168K ﹤0.01%
+13,292
New +$128K
JMBA
7849
CALL
DELISTED
Jamba, Inc.
JMBA
$168K ﹤0.01%
+15,800
New +$152K
CRBP icon
7850
PUT
Corbus Pharmaceuticals
CRBP
$166M
$167K ﹤0.01%
1,100
+187
+20% +$34K

Similar funds

Citadel Advisors's Q2 2018 Portfolio in Review

As of Q2 2018, Citadel Advisors held 9,765 positions worth $203B, up 11% from $184B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Citadel Advisors deployed $8.95B of net new capital in Q2 2018, opening 1,572 new positions and adding to 4,160 existing holdings. Its largest new stake was Equitable Holdings: 16,008,962 shares worth $330M.

By sector, the portfolio is most concentrated in Financials at 6.2% of assets, up from 4.9% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $948M trimmed.

  • Citadel Advisors's largest Q2 2018 buy was Equitable Holdings: 16,008,962 shares worth $330M.
  • Citadel Advisors added most to Citigroup in Q2 2018, an estimated $702M increase.
  • Citadel Advisors's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $948M.
  • Citadel Advisors fully exited Time Warner Inc in Q2 2018, selling an estimated $268M.
  • Citadel Advisors's ten largest holdings make up 24% of its $203B portfolio in Q2 2018.
  • Citadel Advisors opened 1,572 new positions and closed 1,012 in Q2 2018.
  • Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $203B.

Based on Citadel Advisors's 13F filing for Q2 2018, filed 10 Aug 2018.